2-Diphenylmethylpyrrolidine
Chemical compound
| 2-Diphenylmethylpyrrolidine | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
2-Diphenylmethylpyrrolidine is a chemical compound that belongs to the class of pyrrolidine derivatives. It is structurally characterized by a pyrrolidine ring substituted with a diphenylmethyl group.
Chemical Structure
The chemical structure of 2-Diphenylmethylpyrrolidine consists of a five-membered pyrrolidine ring, which is a saturated heterocycle containing one nitrogen atom. The diphenylmethyl group is attached to the second carbon of the pyrrolidine ring. This group consists of a central carbon atom bonded to two phenyl rings.
Synthesis
The synthesis of 2-Diphenylmethylpyrrolidine typically involves the reaction of benzyl chloride with pyrrolidine in the presence of a base. The reaction proceeds through the formation of an intermediate, which then undergoes further reactions to yield the final product.
Pharmacology
The pharmacological properties of 2-Diphenylmethylpyrrolidine are not well-documented. However, compounds with similar structures have been studied for their potential effects on the central nervous system and may exhibit properties such as stimulant or anxiolytic effects.
Applications
2-Diphenylmethylpyrrolidine is primarily used in chemical research and may serve as an intermediate in the synthesis of other complex molecules. Its potential applications in medicine or pharmacology are subjects of ongoing research.
Safety and Handling
As with many chemical compounds, proper safety protocols should be followed when handling 2-Diphenylmethylpyrrolidine. This includes the use of appropriate personal protective equipment (PPE) and adherence to safety guidelines to prevent exposure and accidents.
See also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD